Dianthus Therapeutics Inc. (DNTH) — Capital Reinvestment Ratio

Latest as of September 2023: 0.10x

Dianthus Therapeutics Inc. (DNTH) has a Capital Reinvestment Ratio of 0.10x as of September 2023, meaning it reinvests 0% of its operating cash flow ($1.50 Million) in capital expenditures ($145.00K). Check DNTH tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

$1.50 Million

USD

Capital Expenditures

$145.00K

USD

Data as of

Sep 2023

Most recent filing

Annual Capital Reinvestment Ratio for Dianthus Therapeutics Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Dianthus Therapeutics Inc. from None to None. See Dianthus Therapeutics Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow